Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case–control study

被引:0
作者
L A Anderson
G Gridley
E A Engels
L M Morton
J R Cerhan
W Cozen
R K Severson
S Davis
P Hartge
M S Linet
机构
[1] National Cancer Institute,Division of Cancer Epidemiology and Genetics
[2] Office of Preventative Oncology,Division of Cancer Prevention
[3] National Cancer Institute,Department of Health Sciences Research
[4] Mayo Clinic College of Medicine,Department of Preventive Medicine
[5] The University of Iowa,Department of Pathology
[6] University of Southern California,Department of Family Medicine and Public Health Sciences
[7] University of Southern California,undefined
[8] Karmanos Cancer Institute,undefined
[9] Wayne State University,undefined
[10] Fred Hutchinson Cancer Research Center,undefined
[11] School of Public Health and Community Medicine,undefined
[12] University of Washington,undefined
来源
British Journal of Cancer | 2008年 / 98卷
关键词
lymphoma; non-Hodgkin; antibiotics; case–control study; epidemiology;
D O I
暂无
中图分类号
学科分类号
摘要
Antibiotic use in 759 non-Hodgkin's lymphoma (NHL) patients and 589 controls was compared. Neither total antibiotic use (odds ratio=0.7, 95% confidence interval=0.5–1.2), nor antibiotic use by site, was associated with total NHL, or NHL subtypes. There were no trends with frequency or age at first use (P trend=0.23 and 0.26, respectively).
引用
收藏
页码:161 / 164
页数:3
相关论文
共 114 条
[1]  
Beiderbeck AB(2003)Prescription medications associated with a decreased risk of non-Hodgkin's lymphoma Am J Epidemiol 157 510-516
[2]  
Holly EA(1992)Prior medication use and health history as risk factors for non-Hodgkin's lymphoma: preliminary results from a case–control study in Los Angeles County Cancer Res 52 5510s-5515s
[3]  
Sturkenboom MC(1993)Stratified telephone survey designs Surv Methodol 19 103-113
[4]  
Coebergh JW(2005)Medication use and risk of non-Hodgkin's lymphoma Am J Epidemiol 162 965-974
[5]  
Stricker BH(2004)Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and other cancers Cancer Epidemiol Biomarkers Prev 13 1415-1421
[6]  
Leufkens HG(1996)Risks of non-Hodgkin's lymphoma, multiple myeloma, and leukemia associated with common medications Epidemiology 7 131-139
[7]  
Bernstein L(2002)Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998 J Natl Cancer Inst 94 1204-1210
[8]  
Ross RK(2004)Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case–control study Int J Cancer 111 76-80
[9]  
Casady R(2005)Residential herbicide use and risk of non-Hodgkin lymphoma Cancer Epidemiol Biomarkers Prev 14 934-937
[10]  
Lepowski J(2003)History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL) Int J Cancer 107 99-105